---
schema_version: "secwatch.filing_event.v1"
accession: "0001790340-23-000029"
form_type: "8-K"
ticker: "IMRX"
cik: "0001790340"
company_name: "Immuneering Corp"
filed_at: "2023-06-15T23:59:59+00:00"
generated_at: "2026-06-14T00:27:21.769480+00:00"
event_type: "other"
sentiment: "neutral"
materiality_score: 0.1
calibrated_materiality_score: 0.1
confidence: "high"
source: SEC EDGAR
---

# Immuneering re-elects two directors, ratifies auditor at annual meeting

## Summary
- Peter Feinberg re-elected as Class II director with 18,604,285 votes for, 659,292 withheld.
- Laurie B. Keating re-elected as Class II director with 18,640,672 votes for, 622,905 withheld.
- Ratification of RSM US LLP as auditor approved: 22,595,867 for, 14,843 against, 100 abstain.
- Approximately 77.3% of outstanding shares were represented at the June 14, 2023 meeting.

## SEC filing metadata
- accession: 0001790340-23-000029
- form_type: 8-K
- ticker: IMRX
- cik: 0001790340
- company_name: Immuneering Corp
- filed_at: 2023-06-15T23:59:59+00:00
- event_type: other
- sentiment: neutral
- materiality_score: 0.1
- calibrated_materiality_score: 0.1
- confidence: high
- sec_items: 5.07
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1790340/000179034023000029/0001790340-23-000029-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1790340/000179034023000029/imrx-20230614.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001790340-23-000029
- JSON: https://secwatch.observer/filing/0001790340-23-000029.json
- Plain text: https://secwatch.observer/filing/0001790340-23-000029.txt

## Key facts
- Shareholder Votes
  Immuneering Corp shareholders approved Ratification of the appointment of RSM US LLP as the Company's independent registered public accounting firm for the year ending December 31, 2023. at the 2023-06-14 meeting.
  - Proposal: auditor ratification
  - Outcome: passed
  - Meeting: 2023-06-14
  source text: Votes Votes FOR Votes AGAINST ABSTAINED Broker Non-Votes 22,595,867 14,843 100 0 Based on the foregoing votes, Peter Feinberg and Laurie B.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1790340/000179034023000029/0001790340-23-000029-index.htm
- Shareholder Votes
  Immuneering Corp shareholders approved Election of two Class II directors to serve until the 2026 Annual Meeting of Stockholders, and until their respective successors have been duly elected and qualified. at the 2023-06-14 meeting.
  - Proposal: director election
  - Outcome: passed
  - Meeting: 2023-06-14
  source text: Peter Feinberg 18,604,285 0 659,292 3,347,233 Laurie B. Keating 18,640,672 0 622,905 3,347,233
  evidence_url: https://www.sec.gov/Archives/edgar/data/1790340/000179034023000029/0001790340-23-000029-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.